Danielle R. Mercatante, Ph.D. - Publications
Affiliations: | 2002 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Pharmacology, Oncology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2003 | Bristow CL, Mercatante DR, Kole R. HIV-1 preferentially binds receptors copatched with cell-surface elastase. Blood. 102: 4479-86. PMID 12933574 DOI: 10.1182/Blood-2003-05-1635 | 0.516 | |||
2003 | Ghio AJ, Nozik-Grayck E, Turi J, Jaspers I, Mercatante DR, Kole R, Piantadosi CA. Superoxide-dependent iron uptake: a new role for anion exchange protein 2. American Journal of Respiratory Cell and Molecular Biology. 29: 653-60. PMID 12791678 DOI: 10.1165/Rcmb.2003-0070Oc | 0.527 | |||
2002 | Mercatante DR, Mohler JL, Kole R. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents. The Journal of Biological Chemistry. 277: 49374-82. PMID 12381725 DOI: 10.1074/Jbc.M209236200 | 0.63 | |||
2002 | Mercatante DR, Kole R. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression. Biochimica Et Biophysica Acta. 1587: 126-32. PMID 12084454 DOI: 10.1016/S0925-4439(02)00075-3 | 0.636 | |||
2001 | Mercatante DR, Sazani P, Kole R. Modification of alternative splicing by antisense oligonucleotides as a potential chemotherapy for cancer and other diseases. Current Cancer Drug Targets. 1: 211-30. PMID 12188880 | 0.64 | |||
2001 | Mercatante DR, Bortner CD, Cidlowski JA, Kole R. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells. analysis of apoptosis and cell death. The Journal of Biological Chemistry. 276: 16411-7. PMID 11278482 DOI: 10.1074/Jbc.M009256200 | 0.641 | |||
2000 | Gorman L, Mercatante DR, Kole R. Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs. The Journal of Biological Chemistry. 275: 35914-9. PMID 10969081 DOI: 10.1074/Jbc.M006259200 | 0.589 | |||
2000 | Mercatante D, Kole R. Modification of alternative splicing pathways as a potential approach to chemotherapy Pharmacology and Therapeutics. 85: 237-243. PMID 10739878 DOI: 10.1016/S0163-7258(99)00067-4 | 0.667 | |||
Show low-probability matches. |